Dementia risk following influenza vaccination in a large veteran cohort
Copyright © 2021 Elsevier Ltd. All rights reserved..
BACKGROUND: Two Taiwan based studies indicated influenza vaccinations are associated with lower risk for dementia in patient cohorts with chronic disease. We determined if such associations exist in a large, nationally distributed sample of U.S. patients not selected for chronic disease.
METHODS: Data was obtained from Veterans Health Administration medical records (9/1/2009 - 8/31/19). Eligible patients were ≥65 years of age and free of dementia for two years prior to enrollment through the end of the first influenza season (9/1/2009 to 3/1/2012). Competing risk models estimated the risk of dementia in those with influenza vaccination (n = 66,822) compared to those without vaccination (n = 56,925). Propensity scores and inverse probability of treatment weighting controlled for confounding.
RESULTS: On average, patients were 75.5 (±7.3) years of age, 3.8% were female and 91.6% were white race. After controlling for confounding, patients with influenza vaccination were significantly less likely to develop dementia compared to patients without vaccination (HR = 0.86; 95 %CI:0.83-0.88). Patients with 1, 2 or 3-5 vaccines vs. none had similar risks for dementia and patients with ≥ 6 influenza vaccines vs. none had a significant lower risk for dementia (HR = 0.88, 95 %CI: 0.83-0.94).
CONCLUSIONS: Repeated receipt of influenza vaccinations, compared to remaining unvaccinated, is associated with lower risk for dementia. This is consistent with the hypotheses that vaccinations may reduce risk of dementia by training the immune system and not by preventing specific infectious disease. If vaccines are identified as causative factors in reducing incident dementia, they offer an inexpensive, low-risk intervention with effects greater than any existing preventive measure.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Vaccine - 39(2021), 39 vom: 15. Sept., Seite 5524-5531 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wiemken, Timothy L [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cohort |
---|
Anmerkungen: |
Date Completed 22.10.2021 Date Revised 26.07.2022 published: Print-Electronic CommentIn: Vaccine. 2022 Jun 9;40(26):3528. - PMID 35644207 Citation Status MEDLINE |
---|
doi: |
10.1016/j.vaccine.2021.08.046 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329641468 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329641468 | ||
003 | DE-627 | ||
005 | 20231225205544.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2021.08.046 |2 doi | |
028 | 5 | 2 | |a pubmed24n1098.xml |
035 | |a (DE-627)NLM329641468 | ||
035 | |a (NLM)34420785 | ||
035 | |a (PII)S0264-410X(21)01079-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wiemken, Timothy L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dementia risk following influenza vaccination in a large veteran cohort |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.10.2021 | ||
500 | |a Date Revised 26.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Vaccine. 2022 Jun 9;40(26):3528. - PMID 35644207 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a BACKGROUND: Two Taiwan based studies indicated influenza vaccinations are associated with lower risk for dementia in patient cohorts with chronic disease. We determined if such associations exist in a large, nationally distributed sample of U.S. patients not selected for chronic disease | ||
520 | |a METHODS: Data was obtained from Veterans Health Administration medical records (9/1/2009 - 8/31/19). Eligible patients were ≥65 years of age and free of dementia for two years prior to enrollment through the end of the first influenza season (9/1/2009 to 3/1/2012). Competing risk models estimated the risk of dementia in those with influenza vaccination (n = 66,822) compared to those without vaccination (n = 56,925). Propensity scores and inverse probability of treatment weighting controlled for confounding | ||
520 | |a RESULTS: On average, patients were 75.5 (±7.3) years of age, 3.8% were female and 91.6% were white race. After controlling for confounding, patients with influenza vaccination were significantly less likely to develop dementia compared to patients without vaccination (HR = 0.86; 95 %CI:0.83-0.88). Patients with 1, 2 or 3-5 vaccines vs. none had similar risks for dementia and patients with ≥ 6 influenza vaccines vs. none had a significant lower risk for dementia (HR = 0.88, 95 %CI: 0.83-0.94) | ||
520 | |a CONCLUSIONS: Repeated receipt of influenza vaccinations, compared to remaining unvaccinated, is associated with lower risk for dementia. This is consistent with the hypotheses that vaccinations may reduce risk of dementia by training the immune system and not by preventing specific infectious disease. If vaccines are identified as causative factors in reducing incident dementia, they offer an inexpensive, low-risk intervention with effects greater than any existing preventive measure | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a Cohort | |
650 | 4 | |a Dementia | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Vaccination | |
650 | 7 | |a Influenza Vaccines |2 NLM | |
700 | 1 | |a Salas, Joanne |e verfasserin |4 aut | |
700 | 1 | |a Hoft, Daniel F |e verfasserin |4 aut | |
700 | 1 | |a Jacobs, Christine |e verfasserin |4 aut | |
700 | 1 | |a Morley, John E |e verfasserin |4 aut | |
700 | 1 | |a Scherrer, Jeffrey F |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g 39(2021), 39 vom: 15. Sept., Seite 5524-5531 |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2021 |g number:39 |g day:15 |g month:09 |g pages:5524-5531 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2021.08.046 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2021 |e 39 |b 15 |c 09 |h 5524-5531 |